Procurement Summary
Country: USA
Summary: Assessment of Hosttargeted Nanobody Therapeutics
Deadline: 21 Jan 2026
Posting Date: 08 Jan 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 133327807
Document Ref. No.: HT942626QE003
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Numerous neurotropic viral families are considered high priority pathogens to the Department of War (DOW), but the therapeutic decelopment in stymied by the difficulty of trafficking into into the Central Nervous System (CNS). This is mediated primarily by blood-brain barrier (BBB) tight junctions that prevent large molecules entry into the parenchymal space. However, the CNS has significant physiologically needs in the form of energy, oxygen and other molecular components. See Statement of Objectives (SOO) for specific information.
Notice ID: ht942626qe003
Department/Ind. Agency: dept of defense
Sub-tier: defense health agency (dha)
Office: defense health agency
Product Service Code: aj11 - general science and technology r&d services; general science and technology; basic research
NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Inactive Dates: feb 05, 2026
Inactive Policy: 15 days after response date
Documents
Tender Notice